Literature DB >> 18528753

High-resolution melting analysis for rapid screening of BRCA1 and BRCA2 Spanish mutations.

Inmaculada de Juan1, Eva Esteban, Sarai Palanca, Eva Barragán, Pascual Bolufer.   

Abstract

The majority of BRCA1 and BRCA2 mutation detection procedures include screening methods, all of which are time-consuming. High-resolution melting (HRM) is a promising pre-screening method of gene scanning that combines simplicity and rapid identification of genetic variants. We evaluated HRM in the screening of BRCA1/2 Spanish mutations. We studied 40 BRCA1 and 47 BRCA2 DNA samples with different Spanish mutations. We included a group of 20 unknown DNAs from patients with sporadic breast cancer (BC). The assay was performed with the LightCycler 480 Instrument (Roche). The HRM discriminates all the BRCA1/2 Spanish mutations studied from wild-type DNA. Besides, 54 out of 87 mutations were clearly differentiated from each other. In sporadic BC 11 polymorphisms and three unclassified variants were found in both genes. HRM is a valuable method for rapid screening of BRCA1/2 Spanish mutations and is capable of differentiating new genetic variants in PCR products.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18528753     DOI: 10.1007/s10549-008-0073-7

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  12 in total

1.  LightCycler technology in molecular diagnostics.

Authors:  Elaine Lyon; Carl T Wittwer
Journal:  J Mol Diagn       Date:  2009-02-05       Impact factor: 5.568

2.  Enhanced primer selection and synthetic amplicon templates optimize high-resolution melting analysis of single-nucleotide polymorphisms in a large population.

Authors:  Carol M Bruzzone; Patrick S Tawadros; Lisa A Boardman; Clifford J Steer
Journal:  Genet Test Mol Biomarkers       Date:  2013-06-22

3.  Low prevalence of BRCA1 and BRCA2 mutations in the sporadic breast cancer of Spanish population.

Authors:  Inmaculada de Juan Jiménez; Eva Esteban Cardeñosa; Sarai Palanca Suela; Eva Barragán González; Ismael Aznar Carretero; Blanca Munárriz Gandía; Ana Santaballa Bertran; María Dolores Torregrosa Maicas; Carmen Guillén Ponce; Ana Beatriz Sánchez Heras; Ana Bayón Lara; Oscar Fuster Lluch; Pascual Bolufer Gilabert
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

4.  Relationship of immunohistochemistry, copy number aberrations and epigenetic disorders with BRCAness pattern in hereditary and sporadic breast cancer.

Authors:  Rosa Murria Estal; Sarai Palanca Suela; Inmaculada de Juan Jiménez; Cristina Alenda Gonzalez; Cecilia Egoavil Rojas; Zaida García-Casado; Jose Antonio López Guerrero; María José Juan Fita; Ana Beatriz Sánchez Heras; Ángel Segura Huerta; Ana Santaballa Bertrán; Isabel Chirivella González; Marta Llop García; Gema Pérez Simó; Eva Barragán González; Pascual Bolufer Gilabert
Journal:  Fam Cancer       Date:  2016-04       Impact factor: 2.375

5.  BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.

Authors:  Inmaculada de Juan; Sarai Palanca; Asunción Domenech; Lidia Feliubadaló; Ángel Segura; Ana Osorio; Isabel Chirivella; Miguel de la Hoya; Ana Beatriz Sánchez; Mar Infante; Isabel Tena; Orland Díez; Zaida Garcia-Casado; Ana Vega; Àlex Teulé; Alicia Barroso; Pedro Pérez; Mercedes Durán; Estela Carrasco; M José Juan-Fita; Rosa Murria; Marta Llop; Eva Barragan; Ángel Izquierdo; Javier Benítez; Trinidad Caldés; Dolores Salas; Pascual Bolufer
Journal:  Fam Cancer       Date:  2015-12       Impact factor: 2.375

6.  Screening of the BRCA1 gene in Brazilian patients with breast and/or ovarian cancer via high-resolution melting reaction analysis.

Authors:  Eneida Santos de Oliveira; Bárbara Luisa Soares; Sara Lemos; Reginaldo Cruz Alves Rosa; Angélica Nogueira Rodrigues; Leandro Augusto Barbosa; Débora de Oliveira Lopes; Luciana Lara dos Santos
Journal:  Fam Cancer       Date:  2016-04       Impact factor: 2.375

7.  High resolution melting analysis for a rapid identification of heterozygous and homozygous sequence changes in the MUTYH gene.

Authors:  Rossella Tricarico; Francesca Crucianelli; Antonio Alvau; Claudio Orlando; Roberta Sestini; Francesco Tonelli; Rosa Valanzano; Maurizio Genuardi
Journal:  BMC Cancer       Date:  2011-07-21       Impact factor: 4.430

8.  A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genes.

Authors:  Heather L Hondow; Stephen B Fox; Gillian Mitchell; Rodney J Scott; Victoria Beshay; Stephen Q Wong; Alexander Dobrovic
Journal:  BMC Cancer       Date:  2011-06-24       Impact factor: 4.430

9.  Screening of exon 11 of BRCA1 gene using the high resolution melting approach for diagnosis in Moroccan breast cancer patients.

Authors:  Meryam El Khachibi; Brehima Diakite; Khalil Hamzi; Abdallah Badou; Mohamed Amine Senhaji; Amina Bakhchane; Hassan Jouhadi; Abdelhamid Barakat; Abdellatif Benider; Sellama Nadifi
Journal:  BMC Cancer       Date:  2015-02-25       Impact factor: 4.430

10.  Assessment of high resolution melt analysis feasibility for evaluation of beta-globin gene mutations as a reproducible, cost-efficient and fast alternative to the present conventional method.

Authors:  Mahboubeh Ramezanzadeh; Mansour Salehi; Rasoul Salehi
Journal:  Adv Biomed Res       Date:  2016-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.